Page last updated: 2024-11-07

penicillamine and Hypertrophy, Left Ventricular

penicillamine has been researched along with Hypertrophy, Left Ventricular in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Helou, V1
Bel-Hadj, S1
Drapeau, J1
Clement, R1
Gosselin, H1
Calderone, A1

Other Studies

1 other study available for penicillamine and Hypertrophy, Left Ventricular

ArticleYear
Nitric oxide-mediated inhibition of DNA synthesis was attenuated in hypertrophied neonatal rat ventricular myocytes.
    Nitric oxide : biology and chemistry, 2006, Volume: 14, Issue:4

    Topics: Animals; Animals, Newborn; Cyclic GMP; DNA; Heart Ventricles; Hypertrophy; Hypertrophy, Left Ventric

2006